As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in acne this year.
Experts at Maui Derm Hawaii offer the latest findings and research in treating acne vulgaris in adolescents.
A new study also explores why the incidence of acne vulgaris is higher in girls than boys.
Study investigators evaluated the blood-brain barrier penetrance and lipophilicity of the narrow-spectrum, third-generation tetracycline-class oral antibiotic used for acne treatment.
Transgender and cisgender patients presenting with acne face differences in acne treatment and prescribing patterns.
Researchers say adolescents and young adults using the dermocosmetic product experienced improvements in their acne and quality of life.
Researchers say sun exposure plays a role in the exposome of acne-prone skin.
Researchers said the drug successfully altered C. acnes strains and more in a recent study.
Researchers said using the injections and mesotherapy in patients with acne more effectively treated their acne.
Researchers said the treatment may improve post-acne erythema.
Julie Harper, MD, shared updated risks and benefits of using spironolactone and oral contraceptives to treat acne in women at SCALE 2023.
Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.
A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.
During pregnancy and lactation, physiological changes occur in the body that can impact the development and management of acne.
With hormonal fluctuations, constantly changing schedules, and various afterschool activities, addressing the specific needs of teenage skin becomes essential to promote a lifetime of proper skin care practices.
Catch up on acne vulgaris treatment pearls from Dermatology Times’ most recent Frontline Forum series, featuring James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD.
Yale School of Medicine researchers found tetracycline-class antibiotics were the most prescribed acne treatment for adult female patients between 2002 and 2016.
The impact of acne conglobata on individuals underscores the crucial role dermatologists play in providing effective diagnosis, treatment, and emotional support.
The US Food and Drug Administration has approved IDP-126 gel for patients with acne.
The Sun Pharma survey included 1003 respondents with mild to moderate acne.